Jan 09, 2024 / 01:15AM GMT
Lisa Gill JPMorgan-Analyst
Good afternoon and thank you for joining us. My name is Lisa Gill, and I am Head of Healthcare Services here at JPMorgan. It's with great pleasure this afternoon that we have with us Surgery Partners. Presenting for surgery. Partners are Eric Evans, CEO. And then after Eric does the presentation, he's going to join myself and Dave Doherty for just some Q&A.
So with that, let me turn it over there.
Eric Evans Surgery Partners Inc-Chief Executive Officer
All right. Good afternoon and Happy New Year, everyone. My name is Eric Evans. I'm privileged to serve as the CEO of Surgery Partners. Delighted to always talk about the company. It's always a nice opportunity. I would just -- before I get started, I mentioned that we did pre-release this morning, reiterating our 2023 guidance and providing an earnings of at least or better than $495 million adjusted EBITDA next year. So in case you missed that, just wanted to make sure I said that.
Also, I'm going to do my best to say relatively short on on my
Surgery Partners Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot